Clinical trials
Seizures trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 3 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 6 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Hospital of Fudan University | 4 |
| Longboard Pharmaceuticals | 3 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 3 |
| Eisai Inc. | 2 |
| Affiliated Hospital of Jiangnan University | 1 |
| Beijing Tiantan Hospital | 1 |
| Eisai Co., Ltd. | 1 |
| Epygenix | 1 |
| Jiangxi Qingfeng Pharmaceutical Co. Ltd. | 1 |
| Liu Yonghong | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seizures | 30 |
| Epilepsy | 21 |
| Lennox Gastaut Syndrome | 4 |
| Epilepsies, Myoclonic | 3 |
| Neurodevelopmental Disorders | 3 |
| Tuberous Sclerosis | 2 |
| Angioedema | 1 |
| Apnea | 1 |
| Autoimmune Diseases of the Nervous System | 1 |
| Blood Loss, Surgical | 1 |
Trials
Showing 51 to 30 of 30. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.